Literature DB >> 25947145

Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.

Mardi C Boer1, Corine Prins1, Krista E van Meijgaarden1, Jaap T van Dissel2, Tom H M Ottenhoff3, Simone A Joosten1.   

Abstract

Mycobacterium bovis bacillus Calmette-Guérin (BCG), the only currently available vaccine against tuberculosis, induces variable protection in adults. Immune correlates of protection are lacking, and analyses on cytokine-producing T cell subsets in protected versus unprotected cohorts have yielded inconsistent results. We studied the primary T cell response, both proinflammatory and regulatory T cell responses, induced by BCG vaccination in adults. Twelve healthy adult volunteers who were tuberculin skin test (TST) negative, QuantiFERON test (QFT) negative, and BCG naive were vaccinated with BCG and followed up prospectively. BCG vaccination induced an unexpectedly dichotomous immune response in this small, BCG-naive, young-adult cohort: BCG vaccination induced either gamma interferon-positive (IFN-γ(+)) interleukin 2-positive (IL-2(+)) tumor necrosis factor α-positive (TNF-α(+)) polyfunctional CD4(+) T cells concurrent with CD4(+) IL-17A(+) and CD8(+) IFN-γ(+) T cells or, in contrast, virtually absent cytokine responses with induction of CD8(+) regulatory T cells. Significant induction of polyfunctional CD4(+) IFN-γ(+) IL-2(+) TNF-α(+) T cells and IFN-γ production by peripheral blood mononuclear cells (PBMCs) was confined to individuals with strong immunization-induced local skin inflammation and increased serum C-reactive protein (CRP). Conversely, in individuals with mild inflammation, regulatory-like CD8(+) T cells were uniquely induced. Thus, BCG vaccination either induced a broad proinflammatory T cell response with local inflammatory reactogenicity or, in contrast, a predominant CD8(+) regulatory T cell response with mild local inflammation, poor cytokine induction, and absent polyfunctional CD4(+) T cells. Further detailed fine mapping of the heterogeneous host response to BCG vaccination using classical and nonclassical immune markers will enhance our understanding of the mechanisms and determinants that underlie the induction of apparently opposite immune responses and how these impact the ability of BCG to induce protective immunity to TB.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25947145      PMCID: PMC4478523          DOI: 10.1128/CVI.00162-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  49 in total

1.  A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.

Authors:  D F Hoft; E B Kemp; M Marinaro; O Cruz; H Kiyono; J R McGhee; J T Belisle; T W Milligan; J P Miller; R B Belshe
Journal:  J Lab Clin Med       Date:  1999-09

Review 2.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Authors:  Tom H M Ottenhoff; Frank A W Verreck; Elgin G R Lichtenauer-Kaligis; Marieke A Hoeve; Ozden Sanal; Jaap T van Dissel
Journal:  Nat Genet       Date:  2002-09       Impact factor: 38.330

3.  The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells.

Authors:  Li Li; Dan Qiao; Xianlan Zhang; Zhihui Liu; Changyou Wu
Journal:  Immunobiology       Date:  2010-09-17       Impact factor: 3.144

4.  A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.

Authors:  Natalie E R Beveridge; Helen A Fletcher; Jane Hughes; Ansar A Pathan; Thomas J Scriba; Angela Minassian; Clare R Sander; Kathryn T Whelan; Hazel M Dockrell; Adrian V S Hill; Willem A Hanekom; Helen McShane
Journal:  Tuberculosis (Edinb)       Date:  2008-09-17       Impact factor: 3.131

5.  Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.

Authors:  Daniel Elias; Sven Britton; Abraham Aseffa; Howard Engers; Hannah Akuffo
Journal:  Vaccine       Date:  2008-05-21       Impact factor: 3.641

6.  The time course of the inflammatory response to the Salmonella typhi vaccination.

Authors:  Nicola J Paine; Christopher Ring; Jos A Bosch; Mark T Drayson; Jet J C S Veldhuijzen van Zanten
Journal:  Brain Behav Immun       Date:  2013-01-16       Impact factor: 7.217

7.  CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.

Authors:  Mardi C Boer; Krista E van Meijgaarden; Jérémy Bastid; Tom H M Ottenhoff; Simone A Joosten
Journal:  Eur J Immunol       Date:  2013-05-29       Impact factor: 5.532

8.  Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.

Authors:  T Chiacchio; R Casetti; O Butera; V Vanini; S Carrara; E Girardi; D Di Mitri; L Battistini; F Martini; G Borsellino; D Goletti
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

9.  A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults.

Authors:  Nicole Ritz; Madeleine Strach; Carmen Yau; Binita Dutta; Marc Tebruegge; Tom G Connell; Willem A Hanekom; Warwick J Britton; Roy Robins-Browne; Nigel Curtis
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

10.  Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.

Authors:  Magali Matsumiya; Elena Stylianou; Kristin Griffiths; Zoe Lang; Joel Meyer; Stephanie A Harris; Rosalind Rowland; Angela M Minassian; Ansar A Pathan; Helen Fletcher; Helen McShane
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  22 in total

1.  Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice.

Authors:  V Mohammadi-Shahrokhi; A Rezaei; A Andalib; A Rahnama; A Jafarzadeh; N Eskandari
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

2.  The mechanism of cytoskeleton protein β-actin and cofilin-1 of macrophages infected by Mycobacterium avium.

Authors:  Jianjun Wang; Yongliang Yao; Jianhong Wu; Zhiyong Deng; Tao Gu; Xin Tang; Yang Cheng; Guangxin Li
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

4.  Mycobacterial growth inhibition is associated with trained innate immunity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Sandra M Arend; Corine Prins; Fredrik Oftung; Gro Ellen Korsvold; Sandra V Kik; Rob Jw Arts; Reinout van Crevel; Mihai G Netea; Tom Hm Ottenhoff
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

5.  BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice.

Authors:  Rajesh Kumar Radhakrishnan; Ramya Sivangala Thandi; Deepak Tripathi; Padmaja Paidipally; Madeline Kay McAllister; Sachin Mulik; Buka Samten; Ramakrishna Vankayalapati
Journal:  JCI Insight       Date:  2020-03-12

6.  Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects.

Authors:  Deepti Verma; Venkata Ramanarao Parasa; Johanna Raffetseder; Mihaela Martis; Ratnesh B Mehta; Mihai Netea; Maria Lerm
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

7.  The effects of a psychological intervention directed at optimizing immune function: study protocol for a randomized controlled trial.

Authors:  Lemmy Schakel; Dieuwke S Veldhuijzen; Henriët van Middendorp; Corine Prins; Simone A Joosten; Tom H M Ottenhoff; Leo G Visser; Andrea W M Evers
Journal:  Trials       Date:  2017-05-26       Impact factor: 2.279

Review 8.  Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Front Immunol       Date:  2017-04-05       Impact factor: 7.561

Review 9.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

10.  Mycobacterium tuberculosis.

Authors:  Vishwanath Venketaraman; Deepak Kaushal; Beatrice Saviola
Journal:  J Immunol Res       Date:  2015-08-04       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.